PubMed Health⌕ Search

Biomedical subjects

K Wisborg

Publications and source records attributed to K Wisborg.

31 records · Page 2Linked to original sources
PubMed1976

Halothane anaesthesia and suxamethonium I: the significance of preoperative atropine administration. A double-blind study.

Preoperative administration of atropine was evaluated during induction of halothane anaesthesia with two administrations of suxamethonium 1 mg/kg body weight, 5 min apart. Sixty-eight healthy, adult patients were studied. They were divided into five groups according to dose and route of administration of atropine. ECG was continuously monitored. Serum potassium, pH, PaCO2, PaO2 and standard bicarbonate were measured at appropriate intervals. It was found that neither atropine 0.01 mg/kg body weight given intramuscularly 1 h beofre the anaesthesia nor atropine 0.01 mg/kg body weight given intravenously 5 min prior to induction protected against serious bradycardias (defined as heart rate below 20 beats per minute) following the second dose of suxamethonium. No serious brady-arrhythmias were seen in patients given either a combination of intramuscular and intravenous atropine in the above-mentioned doses or in patients given atropine 0.015 mg/kg body weight intravenously 5 minutes prior to induction. However, a decrease in heart rate to around 40-50 beats per minute occurred in some of these patients. Furthermore, these large doses of atropine caused an increase in heart rate during induction to more than 120 beats per minute in about 50% of the patients and to more than 140 beats per minute in about 25% of the patients. Our results suggest that preoperative administration of atropine does not protect against serious brady-arrhythmias following a second dose of suxamethonium, unless doses of atropine are used which cause tachycarida of considerable degree.

Adolescent↗
PubMed1975

The effects of althesin on arterial pressure, pulse rate preganglionic sympathetic activity and barostatic reflexes in cats.

We have studied the effects of Althesin on preganglionic cervical sympathetic nervous activity, arterial pressure, pulse rate and barostatic reflexes in cats. Normal, baroreceptor denervated and decerebrate animals were studied. On the basis of our finding it is concluded that Althesin severely depresses sympathetic nervous activity by action on the vasomotor centre. The depression of arterial pressure however was only moderate due to two compensatory mechanisms: a vagolytic action of Althesin and a peripheral vascular effect believed to be caused by an enhanced action of catecholamines caused by Althesin. Barostatic reflexes were found active under conditions where Althesin did not totally abolish sympathetic tone.

Alfaxalone Alfadolone Mixture↗
PubMed1975

The effect of induced arterial hypertension upon regional blood flow in subcutaneous tissue in patients with arterial insufficiency of the legs.

In nine patients with arterial insufficiency of the legs, the effect of induced arterial hypertension upon blood flow in subcutaneous tissue was correlated to the changes of blood flow in subcutaneous tissue during dependency. Arterial pressure was increased by constant intravenous infusion of angiotensin. Blood flow in subcutaneous tissue was measured 10 cm distal to the head of fibula, at the lateral malleolus, and at the base of the first toe by means of the xenon washout technique. It was found that in areas where blood flow decreased during dependency, blood flow decreased during angiotensin infusion. An increase in blood flow during angiotensin infusion was seen in areas where blood flow increased during dependency. It is concluded that the effect of angiotensin infusion on blood flow and of therapeutically induced hypertension can be predicted from the effect of orthostatic changes on blood flow. The results obtained support the hypothesis that the vessels behave as passive channels (i.e. blood flow depends mainly upon arterial perfusion pressure) in areas where the normal vasoconstrictor response to increased transmural pressure is abolished.

Angiotensin II↗